Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | InMode Ltd.✕ INMD · #10,066 in the world | Protek✕ PRTK.ME |
|---|---|---|
| Profile | ||
| Country | 🇮🇱 Israel | 🇷🇺 Russia |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | — |
| Founded | 2008 | 1990 |
| Size | ||
| Market cap | $859 M | |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | InMode Ltd. | Protek |
|---|---|---|
| 2025 | $371 MSEC | — |
| 2024 | $395 MSEC | — |
| 2023 | $492 MSEC | — |
| 2022 | $454 MSEC | — |
| 2021 | $358 MSEC | — |
| 2020 | $206 MSEC | — |
| 2019 | $156 MSEC | — |
| 2018 | $100 MSEC | — |
| 2017 | $53 MSEC | $4.4 BWD |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| Revenue | $371 M | — |
|---|
| Net income | $94 M | — |
|---|
| Employees | 660 | 12,000 |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 9.2× | — |
| Price to sales | 2.3× | — |
| Price to book | 1.3× | — |
| Free cash flow yield | 9.8% | — |
| Profitability | ||
|---|---|---|
| Gross margin | 78.5% | — |
| Operating margin | 23.1% | — |
| Net margin | 25.3% | — |
| Return on equity | 13.5% | — |
| Growth | ||
|---|---|---|
| Revenue growth | -6.2% | — |
| Revenue growth, 3 years a year | -6.6% | — |
| Earnings per share growth | -36.4% | — |
| Cash | ||
|---|---|---|
| Free cash flow margin | 22.8% | — |
| Shareholder returns | ||
|---|---|---|
| Shareholder yield | 14.8% | — |
| Altman Z-score zone | safe | — |
|---|
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Jan 2020 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.